Monocl raised $3.4M from GP Bullhound.
Monocl, a Gothenburg, Sweden-based company providing a software as a service solution for the life science industry, announced in a press release closing in a €3M ($3.4M) capital investment round.
The funding was provided by the Nordic investment house GP Bullhound and will be used to expand Monocl’s US presence, including opening the US Headquarters in Boston, Massachusetts. The investment will also be used to grow and expand sales, marketing, customer success and product development teams in targeted markets.
Monocl, founded in 2011 and led by CEO Björn Carlsson, is a stakeholder mapping and management provider to the life science industry. The company built a platform that helps professionals to target and engage opinion leaders, physicians and scientists in a way that streamlines development cycles, increases efficiency and boosts profitability. Monocl is worrking with a range of industry clients, including names such as Pfizer, Novartis, Takeda and AstraZeneca.
Prior to this deal, Monocl raised almost $3M.